Cassava Sciences, Inc. (SAVA)
NASDAQ: SAVA · Real-Time Price · USD
2.290
-0.030 (-1.29%)
Aug 13, 2025, 2:51 PM - Market open
Paramount Global Market Cap
Cassava Sciences has a market cap or net worth of $110.63 million as of August 13, 2025. Its market cap has decreased by -84.55% in one year.
Market Cap
110.63M
Enterprise Value
-5.25M
1-Year Change
-84.55%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since July 14, 2000, Cassava Sciences's market cap has decreased from $212.59M to $110.63M, a decrease of -47.96%. That is a compound annual growth rate of -2.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 112.07M | -1.29% |
| Dec 31, 2024 | 113.54M | -88.04% |
| Dec 29, 2023 | 949.34M | -22.98% |
| Dec 30, 2022 | 1.23B | -29.52% |
| Dec 31, 2021 | 1.75B | 633.58% |
| Dec 31, 2020 | 238.38M | 166.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |